ShangBay Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
6
- Investments
-
88
- Portfolio
-
54
- Exits
-
17
ShangBay Capital General Information
Company Description
Founded in 2015, ShangBay Capital is a venture capital firm based in Palo Alto, California. The firm prefers to invest in companies operating in the life sciences, medical devices, biotechnology, and mobile healthcare sectors across the United States. This firm is a Registered Investment Adviser (RIA).
Business Details
Website
www.shangbaycapital.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- 1555 Alma Street
- Palo Alto, CA 94301
- United States
ShangBay Capital Investments (88)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Evident Vascular | 25-Mar-2025 | Early Stage VC | Diagnostic Equipment | Generating Revenue | ||
| Fluid Biomed | 16-Nov-2024 | Therapeutic Devices | Clinical Trials - General | |||
| Venova Medical | 04-Sep-2024 | Therapeutic Devices | Clinical Trials - General | |||
| Aveta System | 17-May-2024 | Surgical Devices | Generating Revenue | |||
| Nervonik | 05-Mar-2024 | Therapeutic Devices | Generating Revenue | |||
| Petal Surgical | 01-Mar-2024 | Other Healthcare Technology Systems | Startup | |||
| Inquis Medical | 28-Feb-2024 | Therapeutic Devices | Clinical Trials - General | |||
| Avation Medical | 15-Dec-2023 | Therapeutic Devices | Generating Revenue | |||
| Sonovascular | 31-Jul-2023 | Later Stage VC | Surgical Devices | Clinical Trials - Phase 1 | ||
| Laplace Interventional | 20-Jul-2023 | Early Stage VC | Surgical Devices | Generating Revenue |
ShangBay Capital Exits (17)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Tvardi Therapeutics | 15-Apr-2025 | Reverse Merger | |
| Ceribell | 11-Oct-2024 | ||
| Refuge Biotech | 03-Aug-2023 | ||
| Alpine BioTherapeutics | 26-May-2023 | ||
| Lucira Health | 22-Feb-2023 | ||
| QuanDx | 01-Dec-2022 | ||
| Apexigen | 01-Aug-2022 | ||
| Sightstream | 25-May-2022 | ||
| Qool Therapeutics | 12-Oct-2021 | Bankruptcy: Liquidation | |
| DeVoro Medical | 21-Sep-2021 | Merger/Acquisition |
ShangBay Capital Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
ShangBay Capital Co-Investors (220)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| AIM-HI | 3 |
|
|
||
| SV Tech Ventures |
|
|
|||
| Boston Scientific |
|
|
|||
| Founders Fund |
|
|
|||
| Pfizer Ventures |
|
|
ShangBay Capital FAQs
-
What is ShangBay Capital?
Founded in 2015, ShangBay Capital is a venture capital firm based in Palo Alto, California.
-
When was ShangBay Capital founded?
ShangBay Capital was founded in 2015.
-
Where is ShangBay Capital headquartered?
ShangBay Capital is headquartered in Palo Alto, CA.
-
What is ShangBay Capital's total asset value?
ShangBay Capital has around in total assets under management.
-
How many investments has ShangBay Capital made?
ShangBay Capital has made 88 investments.
-
What has ShangBay Capital invested in?
ShangBay Capital has made numerous investments in companies like Evident Vascular, Fluid Biomed, and Venova Medical within the Diagnostic Equipment and Therapeutic Devices industries.
-
What has ShangBay Capital invested in recently?
ShangBay Capital's latest investment was on 25-Mar-2025 in Evident Vascular, a company within the Diagnostic Equipment industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
